TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,910 | +219.6% | 62,145 | +470.1% | 0.00% | – |
| Q1 2023 | $9,047 | -48.5% | 10,900 | -51.6% | 0.00% | – |
| Q4 2022 | $17,550 | -56.1% | 22,500 | -39.8% | 0.00% | – |
| Q3 2022 | $40,000 | +566.7% | 37,400 | +240.0% | 0.00% | – |
| Q2 2022 | $6,000 | -53.8% | 11,000 | -19.1% | 0.00% | – |
| Q1 2022 | $13,000 | -94.4% | 13,600 | -94.0% | 0.00% | – |
| Q4 2021 | $232,000 | -4.5% | 226,460 | +142.7% | 0.00% | – |
| Q2 2021 | $243,000 | -75.2% | 93,300 | -71.6% | 0.00% | – |
| Q1 2021 | $980,000 | +103.3% | 328,700 | +123.9% | 0.00% | – |
| Q4 2020 | $482,000 | – | 146,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 2 | $1 | 0.00% |
| Westside Investment Management, Inc. | 4 | $2 | 0.00% |
| Global Wealth Strategies & Associates | 40 | $19 | 0.00% |
| Cape Investment Advisory, Inc. | 1 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 157 | $73 | 0.00% |
| Nemes Rush Group LLC | 1 | $1 | 0.00% |
| Renaissance Technologies | 135,710 | $64 | 0.00% |
| VANGUARD GROUP INC | 82,051 | $38,892 | 0.00% |
| UBS Group AG | 4 | $2 | 0.00% |
| OSAIC HOLDINGS, INC. | 50 | $22 | 0.00% |